{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:46:20Z","timestamp":1775598380228,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jgo.2022.10.016","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T01:48:19Z","timestamp":1668736099000},"page":"101401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study"],"prefix":"10.1016","volume":"14","author":[{"given":"Javier","family":"de la Rubia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso J.","family":"Cruz-Jentoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto P\u00e9rez","family":"Persona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Zudaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gironella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Arnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Encinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Alfonso","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel Ram\u00edrez","family":"Payer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Bonanad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2022.10.016_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3324\/haematol.2015.126771","article-title":"Aging and blood disorders: new perspectives, new challenges","volume":"4","author":"Bron","year":"2015","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2022.10.016_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03324793","article-title":"Upper age limits in studies submitted to a research ethics committee","volume":"2","author":"Cruz-Jentoft","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jgo.2022.10.016_bb0015","article-title":"Optimal management of elderly cancer patients: usefulness of the comprehensive geriatric assessment","volume":"1645-60","author":"Caillet","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jgo.2022.10.016_bb0020","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"22","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdt386","article-title":"An update on a systematic review of the use of geriatric assessment for older adults in oncology","volume":"2","author":"Puts","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgo.2013.04.002","article-title":"Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment","volume":"3","author":"Ramjaun","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger","volume":"2","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0040","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S1470-2045(12)70259-0","article-title":"Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review","volume":"10","author":"Hamaker","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0045","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"24","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0050","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report","volume":"13","author":"Palumbo","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.jgo.2022.10.016_bb0055","article-title":"Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score","volume":"9","author":"Kleber","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jgo.2022.10.016_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clml.2013.03.013","article-title":"Validation of the Freiburg comorbidity index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome","volume":"5","author":"Kleber","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jgo.2022.10.016_bb0065","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised myeloma comorbidity index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"5","author":"Engelhardt","year":"2017","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2022.10.016_bb0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jgo.2015.03.003","article-title":"Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: the GAH scale","volume":"5","author":"Bonanad","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jgo.2016.12.008","article-title":"Further psychometric validation of the GAH scale: responsiveness and effect size","volume":"3","author":"Cruz-Jentoft","year":"2017","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2022.10.016_bb0080","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.clml.2015.07.266","article-title":"GAH Scale is a Simple, Comprehensive Assessment Tool in Older Patients With Hematological Malignancies That Shows Mortality Prediction Capacities","volume":"9","author":"de la Rubia","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jgo.2022.10.016_bb0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do a regression analysis","volume":"3","author":"Green","year":"1991","journal-title":"Multivar Behav Res"},{"key":"10.1016\/j.jgo.2022.10.016_bb0090","first-page":"501","article-title":"Regression modeling strategies","volume":"6","author":"Nunez","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0095","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/era.10.127","article-title":"Chronic lymphocytic leukemia: planning for an aging population","volume":"9","author":"Gribben","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jgo.2022.10.016_bb0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/JOP.18.00180","article-title":"Practical assessment and Management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology summary","volume":"7","author":"Mohile","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jgo.2022.10.016_bb0105","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","article-title":"Geriatric assessment in multiple myeloma patients: validation of the international myeloma working group (IMWG) score and comparison with other common comorbidity scores","volume":"9","author":"Engelhardt","year":"2016","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2022.10.016_bb0110","article-title":"A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK myeloma research Alliance risk profile): a development and validation study","volume":"3","author":"Cook","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0115","article-title":"Development of a Medicare health outcomes survey deficit-accumulation frailty index and its application to older patients with newly diagnosed multiple myeloma","volume":"2","author":"Mian","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.jgo.2022.10.016_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41375-019-0539-0","article-title":"A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial","volume":"1","author":"Facon","year":"2020","journal-title":"Leukemia."},{"key":"10.1016\/j.jgo.2022.10.016_bb0125","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma","volume":"11","author":"Milani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jgo.2022.10.016_bb0130","article-title":"Frailty assessment in the care of older people with haematological malignancies","volume":"11","author":"Goede","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jgo.2022.10.016_bb0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jgo.2015.10.183","article-title":"Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy","volume":"6","author":"Park","year":"2015","journal-title":"J Geriatr Oncol"},{"issue":"s2","key":"10.1016\/j.jgo.2022.10.016_bb0140","article-title":"Feasibility and efficacy of dose adjusted melphalan -prednisone bortezomib (MPV) in patients \u2265 75 years with newly diagnosed multiple myeloma; preliminary results of the phase II HOVON 123 study","volume":"102","author":"Zweegman","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2022.10.016_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/EDBK_239067","article-title":"Approach to the older adult with multiple myeloma","author":"Mina","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822005203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822005203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T11:43:53Z","timestamp":1724759033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406822005203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1879406822005203"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2022.10.016","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2022.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101401"}}